160 related articles for article (PubMed ID: 19880564)
21. Expression of B-cell activating factor of the tumour necrosis factor family (BAFF) in T cells in active systemic lupus erythematosus: the role of BAFF in T cell-dependent B cell pathogenic autoantibody production.
Morimoto S; Nakano S; Watanabe T; Tamayama Y; Mitsuo A; Nakiri Y; Suzuki J; Nozawa K; Amano H; Tokano Y; Kobata T; Takasaki Y
Rheumatology (Oxford); 2007 Jul; 46(7):1083-6. PubMed ID: 17500077
[TBL] [Abstract][Full Text] [Related]
22. Regression of systemic lupus erythematosus after development of an acquired toll-like receptor signaling defect and antibody deficiency.
Visentini M; Conti V; Cagliuso M; Tinti F; Siciliano G; Trombetta AC; Mitterhofer AP; Fiorilli M; Quinti I
Arthritis Rheum; 2009 Sep; 60(9):2767-71. PubMed ID: 19714644
[TBL] [Abstract][Full Text] [Related]
23. A compass that points to lupus: genetic studies on type I interferon pathway.
Kyogoku C; Tsuchiya N
Genes Immun; 2007 Sep; 8(6):445-55. PubMed ID: 17581625
[TBL] [Abstract][Full Text] [Related]
24. Cross-reactivity of human lupus anti-DNA antibodies with alpha-actinin and nephritogenic potential.
Zhao Z; Weinstein E; Tuzova M; Davidson A; Mundel P; Marambio P; Putterman C
Arthritis Rheum; 2005 Feb; 52(2):522-30. PubMed ID: 15693007
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of the cross-reaction between anti-DNA and anti-cardiolipin antibodies in SLE and experimental animals.
Eilat D; Zlotnick AY; Fischel R
Clin Exp Immunol; 1986 Aug; 65(2):269-78. PubMed ID: 3491705
[TBL] [Abstract][Full Text] [Related]
26. Genesis and pathogenicity of anti-DNA antibodies.
Fournie GJ; Izui S; Lambert PH; Conte JJ
Adv Nephrol Necker Hosp; 1976; 6():47-61. PubMed ID: 139082
[TBL] [Abstract][Full Text] [Related]
27. Characterization of autoantibody activities in sera anti-DNA antibody and circulating immune complexes from 12 systemic lupus erythematosus patients.
Adyel FZ; Hentati B; Boulila A; Hachicha J; Ternynck T; Avrameas S; Ayadi H
J Clin Lab Anal; 1996; 10(6):451-7. PubMed ID: 8951619
[TBL] [Abstract][Full Text] [Related]
28. Specific and shared idiotypes found on hybridoma anti-DNA autoantibodies derived from rheumatoid arthritis and systemic lupus erythematosus patients.
Rauch J; Massicotte H; Tannenbaum H
J Immunol; 1985 Oct; 135(4):2385-92. PubMed ID: 3875652
[TBL] [Abstract][Full Text] [Related]
29. Anti-DNA antibodies in systemic lupus erythematosus.
Pisetsky DS
Rheum Dis Clin North Am; 1992 May; 18(2):437-54. PubMed ID: 1626077
[TBL] [Abstract][Full Text] [Related]
30. TLR9/MyD88 signaling is required for class switching to pathogenic IgG2a and 2b autoantibodies in SLE.
Ehlers M; Fukuyama H; McGaha TL; Aderem A; Ravetch JV
J Exp Med; 2006 Mar; 203(3):553-61. PubMed ID: 16492804
[TBL] [Abstract][Full Text] [Related]
31. Role of pathogenic auto-antibody production by Toll-like receptor 9 of B cells in active systemic lupus erythematosus.
Nakano S; Morimoto S; Suzuki J; Nozawa K; Amano H; Tokano Y; Takasaki Y
Rheumatology (Oxford); 2008 Feb; 47(2):145-9. PubMed ID: 18160420
[TBL] [Abstract][Full Text] [Related]
32. Anti-DNA antibodies: a diagnostic and prognostic tool for systemic lupus erythematosus?
Riboldi P; Gerosa M; Moroni G; Radice A; Allegri F; Sinico A; Tincani A; Meroni PL
Autoimmunity; 2005 Feb; 38(1):39-45. PubMed ID: 15804704
[TBL] [Abstract][Full Text] [Related]
33. DNA hypomethylation is crucial for apoptotic DNA to induce systemic lupus erythematosus-like autoimmune disease in SLE-non-susceptible mice.
Wen ZK; Xu W; Xu L; Cao QH; Wang Y; Chu YW; Xiong SD
Rheumatology (Oxford); 2007 Dec; 46(12):1796-803. PubMed ID: 18032537
[TBL] [Abstract][Full Text] [Related]
34. The structure of human lupus anti-DNA antibodies.
Zouali M
Methods; 1997 Jan; 11(1):27-35. PubMed ID: 8990086
[TBL] [Abstract][Full Text] [Related]
35. The role of innate immunity in autoimmune tissue injury.
Allam R; Anders HJ
Curr Opin Rheumatol; 2008 Sep; 20(5):538-44. PubMed ID: 18698174
[TBL] [Abstract][Full Text] [Related]
36. Production of anti-Ro/SS-A and anti-La/SS-B autoantibodies is closely coordinated in systemic lupus erythematosus and independent of anti-dsDNA production.
Meilof JF; Veldhoven CH; Swaak AJ; Smeenk RJ
J Autoimmun; 1997 Feb; 10(1):67-75. PubMed ID: 9080301
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of lupus disease by anti-double-stranded DNA antibodies of the IgM isotype in the (NZB x NZW)F1 mouse.
Werwitzke S; Trick D; Kamino K; Matthias T; Kniesch K; Schlegelberger B; Schmidt RE; Witte T
Arthritis Rheum; 2005 Nov; 52(11):3629-38. PubMed ID: 16255055
[TBL] [Abstract][Full Text] [Related]
38. A common anti-DNA idiotype and other autoantibodies in sera of offspring of mothers with systemic lupus erythematosus.
el-Roeiy A; Gleicher N; Isenberg D; Kennedy RC; Shoenfeld Y
Clin Exp Immunol; 1987 Jun; 68(3):528-34. PubMed ID: 3115649
[TBL] [Abstract][Full Text] [Related]
39. [Pathogenic role of antinuclear antibodies in lupus disease].
Sany J
Ann Med Interne (Paris); 1990; 141(3):222-6. PubMed ID: 2195947
[TBL] [Abstract][Full Text] [Related]
40. Auto-anti-anti-DNA antibodies from SLE patients and normals.
Taniguchi O; Chia DS; Barnett EV
J Rheumatol; 1984 Jun; 11(3):291-7. PubMed ID: 6610752
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
